The characteristics described in this table are general. The intra-aortic balloon pump has been excluded since to it does not generate its own volume stroke. *Clinical approval of ECMO is variable ...

Despite major advances in the treatment of heart failure over the past 2 decades improving the natural history of this condition, heart failure continues to be a major source of morbidity and ...

Supervised exercise training is safe and improves peak oxygen consumption, walking distance, and quality of life in patients with left ventricular assist devices, per a recent meta-analysis.

After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

"This is a landmark event for children suffering from terminal heart failure." Charles D. Fraser, Jr., MD, Texas Children’s Hospital THE WOODLANDS, Tex., and BERLIN, Dec. 16, 2011—The Berlin Heart ...

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced a collaboration with The Artificial Heart Laboratory at the Foundation of ...

The Centers for Medicare and Medicaid Services today proposed coverage policy updates regarding artificial hearts and ventricular assist devices for patients with advanced heart failure. The proposed ...

Israeli tech company Leviticus Cardio has created a unique system that allows for wireless charging of a ventricular assist device (VAD). Previously VADs charged via a power cord that runs from the ...

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Left Ventricular Assist Devices Market Size, Trends and Insights By Product (Left ...

The U.S. FDA posted notice of a recall of the system monitor for the Heartmate left ventricular assist device by Abbott Laboratories, an action necessitated by ...

LONDON--(BUSINESS WIRE)--The ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. Request free ...